Effects of the spin trap alpha-phenyl N-tert-butyl nitrone on myocardial function and flow: a dose-response study in the open-chest dog and in the isolated rat heart

Free Radical Biology & Medicine
X Y LiR Bolli

Abstract

Alpha-phenyl N-tert-butyl nitrone (PBN) is widely used in spin-trapping experiments, but its possible toxicity has not been systematically evaluated. The purpose of this study was to investigate the effects of different doses of PBN on cardiac function in vivo (open-chest dogs) and in vitro (isolated rat hearts). In open-chest dogs, PBN was infused intracoronarily to achieve coronary arterial concentrations ranging from 1.6 mM to 10.0 mM. At coronary arterial concentrations of 1.6 mM and 2.5 mM, PBN had no appreciable effect on regional myocardial function (assessed as systolic wall thickening). However, coronary arterial concentrations of PBN of 5.0 mM and 10.0 mM produced a marked reduction and, eventually, a complete loss of systolic wall thickening (53% of baseline values after 30 min at 5.0 mM and 14% after 30 min at 10.0 mM). Furthermore, PBN increased coronary blood flow by approximately 25% at 2.5 mM and by > 100% at 10.0 mM. In isolated rat hearts, perfusion with 2.5 and 5.0 mM PBN for 60 min did not significantly affect global myocardial function, assessed as developed pressure, rate-pressure product, and positive and negative dP/dt. At the 10.0 mM concentration, however, these variables were significantly decreased a...Continue Reading

References

Apr 1, 1992·Journal of Molecular and Cellular Cardiology·S BradamanteF Piccinini
Mar 1, 1991·Cardiovascular Drugs and Therapy·R Bolli
Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R BolliP B McCay
Jan 1, 1987·Free Radical Biology & Medicine·C M ArroyoW B Weglicki
Jan 17, 1985·The New England Journal of Medicine·J M McCord
Dec 31, 1985·Biochemical and Biophysical Research Communications·A NodaM Hirata
Jul 1, 1980·Circulation Research·S WallensteinJ L Fleiss
Aug 1, 1980·Journal of Molecular and Cellular Cardiology·C GuarnieriC M Caldarera

❮ Previous
Next ❯

Citations

Jan 1, 1996·Free Radical Biology & Medicine·C F SchaeferS D Kosanke
May 1, 1997·Journal of Ethnopharmacology·W J CullenS Dutta
Feb 22, 2001·Free Radical Biology & Medicine·L J BerlinerT L Clanton
Mar 10, 2001·Antioxidants & Redox Signaling·Y Kotake
Aug 14, 2003·Fundamental & Clinical Pharmacology·Catherine VergelyLuc Rochette
Nov 6, 2009·Hemodialysis International·Lindsay J ChestertonChris W McIntyre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.